Windhover Information's FDA/CMS Summit for Biopharmaceutical Executives (Business Wire via Yahoo! Finance)
NORWALK, Conn.----The most pressing regulatory, marketing and legal issues for health care industry executives will be expertly handled by the top names in FDA, CMS and industry at Windhover's FDA-CMS Summit, scheduled for Dec. 4-5 in Washington, DC.

FDA Awards PTC Therapeutics Orphan Products Development Grant For The Development Of PTC124 In Duchenne Muscular (Medical News Today)
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery and development of small-molecule drugs targeting post-transcriptional control mechanisms, today announced it has been awarded a two-year grant from the Office of Orphan Products Development (OOPD) Grant Program of the U.S. Food and Drug Administration (FDA). [click link for full article]

Windhover Information's FDA/CMS Summit for Biopharmaceutical Executives (RedNova)
The most pressing regulatory, marketing and legal issues for health care industry executives will be expertly handled by the top names in FDA, CMS and industry at Windhover's FDA-CMS Summit, scheduled for Dec. 4-5 in Washington, DC. Just added to the agenda is Steven E.